Cargando…
Treatment patterns in people with cystic fibrosis: have they changed since the introduction of ivacaftor?
BACKGROUND: In late 2012, ivacaftor became available in the UK for people with cystic fibrosis (CF) aged 6 years and over with a G551D mutation. Long-term changes in treatment patterns have not previously been reported. We investigated long-term treatment patterns in people with CF with a G551D muta...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9097695/ https://www.ncbi.nlm.nih.gov/pubmed/34497037 http://dx.doi.org/10.1016/j.jcf.2021.08.014 |